Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Hypertension (Dallas, Tex. : 1979)|March 16, 2005
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious ratsPia E Walters, Tracey A Gaspari, Robert E WiddopAtherosclerosis|February 20, 2008
Angiotensin IV-evoked vasoprotection is conserved in advanced atheromaAntony Vinh, Robert E Widdop, Siew Yeen Chai, et al.International Journal of Vascular Medicine|July 19, 2013
Chronic NaHS Treatment Is Vasoprotective in High-Fat-Fed ApoE(-/-) MiceAsha Ford, Mohammad Al-Magableh, Tracey A Gaspari, et al.Cardiovascular Research|November 17, 2007
Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient miceAntony Vinh, Robert E Widdop, Grant R Drummond, et al.Frontiers in Pharmacology|August 28, 2020
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1Anita A Pinar, Alexander Yuferov, Tracey A Gaspari, et al.British Journal of Pharmacology|March 3, 2004
Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aortaRuth E Hannan, Tracey A Gaspari, Elizabeth A Davis, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2019
Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblastsFelipe Tapia Cáceres, Tracey A Gaspari, Chrishan S Samuel, et al.International Journal of Molecular Sciences|July 9, 2022
Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) ReceptorsFelipe Tapia Cáceres, Tracey A Gaspari, Mohammed Akhter Hossain, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient miceSonja Tesanovic, Antony Vinh, Tracey A Gaspari, et al.Pharmacology & Therapeutics|September 23, 2008
AT2 receptors: functional relevance in cardiovascular diseaseEmma S Jones, Antony Vinh, Claudia A McCarthy, et al.Pageof 3